Valuation: Seer, Inc.

Market Cap 119M 104M 96M 88.09M 167M 11.44B 170M 1.14B 450M 5.59B 446M 436M 19.29B P/E 2026 *
-2.07x
P/E 2027 * -2.2x
Enterprise Value 119M 104M 96M 88.09M 167M 11.44B 170M 1.14B 450M 5.59B 446M 436M 19.29B EV / Sales 2026 *
7.31x
EV / Sales 2027 * 5.67x
Free-Float
85.54%
Yield 2026 *
-
Yield 2027 * -
1 week-1.82%
Current month+30.12%
1 month+26.32%
3 months+5.37%
6 months+14.29%
Current year+18.03%
1 week 2.14
Extreme 2.14
2.19
1 month 1.55
Extreme 1.55
2.34
Current year 1.55
Extreme 1.55
2.34
1 year 1.55
Extreme 1.55
2.41
3 years 1.46
Extreme 1.455
5.65
5 years 1.46
Extreme 1.455
45.85
10 years 1.46
Extreme 1.455
86.55
Manager TitleAgeSince
Chief Executive Officer 57 2018-02-28
Director of Finance/CFO 58 2020-04-30
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 68 2024-08-12
Director/Board Member 70 2017-11-30
Director/Board Member 76 2017-11-30
Date Insider Type Main position Quantity % Market Cap.
7/8/26 Sell

Director

-10,660 0.0193%
5/20/26 Sell

Chief Financial Officer

-7,303 0.0129%
5/8/26 Free

Executive/Senior Manager

300,000 0.5317%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-1.82%+1.89%-54.81% 119M
+1.41%+3.65%+12.74%+0.24% 26.6B
-0.93%+0.63%+23.80%-4.56% 7.6B
-1.09%+0.37%+91.32%+173.22% 4.2B
-0.65%+4.23%+10.41%-46.64% 2.85B
-6.70%+2.64%+88.74%+65.07% 2.53B
-3.84%-20.54%+148.44%+107.92% 2.08B
-2.86%-15.07%+15.83%+9.61% 1.73B
-3.19%-10.57%-15.27%+35.72% 1.24B
+0.37%-6.78%+97.64%+65.84% 939M
Average -1.74%-2.22%+47.55%+35.16% 4.99B
Weighted average by Cap. -0.18%+1.82%+31.39%+21.47%

Financials

2026 *2027 *
Net sales 16.25M 14.2M 13.14M 12.05M 22.81M 1.57B 23.21M 157M 61.54M 765M 61.03M 59.68M 2.64B 20.95M 18.31M 16.94M 15.54M 29.41M 2.02B 29.92M 202M 79.34M 986M 78.68M 76.95M 3.4B
Net income -58.65M -51.27M -47.41M -43.51M -82.34M -5.65B -83.77M -565M -222M -2.76B -220M -215M -9.53B -55.7M -48.69M -45.03M -41.32M -78.2M -5.37B -79.56M -537M -211M -2.62B -209M -205M -9.05B
Net Debt - -
Logo Seer, Inc.
Seer, Inc. is a life sciences company. It is developing products that open a new gateway to the proteome. Its Proteograph product suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. The Proteograph has detected over 36,000 proteins across multiple species, and its performance and capabilities have been demonstrated in over 33 peer-reviewed publications, preprints and reviews. The Proteograph Product Suite is detector-agnostic and is adaptable to other protein detection instruments. The MS component of the Proteograph workflow is either provided by the researcher’s laboratory, can be outsourced to a third-party provider, or be run through the Seer Technology Access Center (STAC), which is its in-house service program. It has launched Proteograph XT, which enhances the sample throughput of the Proteograph Product Suite and MS instrument.
Employees
124
Date Price Change Volume
26-07-16 US$2.160 0.00% 202,167
26-07-15 US$2.160 0.00% 310,397
26-07-14 US$2.160 -0.46% 142,655
26-07-13 US$2.170 0.00% 365,132
26-07-10 US$2.170 -1.36% 301,330
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.160USD
Average target price
4.000USD
Spread / Average Target
+85.19%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SEER Stock